Propentofylline

This classification denotes a neuroprotective agent with the molecular formula C15H22N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5RTA398U4H, chemically known as 3,7-dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-1h-purine-2,6-dione but more generally known as propentofylline, which bears US NIH Compound Identifier 4938. European Medicines Agency schedules Propentofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10102MIG. The term PROPENTOFYLLINE is an International Non-Proprietary Name. World Health Organization schedules propentofylline in its Anatomical Therapeutic Chemical (ATC) Classification. PROPENTOFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule propentofylline under HS 29395900 and SITC 54145. As of Q4 2014, PROPENTOFYLLINE remains US FDA's Preferred Term for this commodity. Propentofylline bears US NLM identifiers UMLS ID C0072171 and NCI Concept Code C81919. SMILES: O=C1N(CCCCC(=O)C)C(=O)N(C2NCN(C12)CCC)C.